To determine the effect of transfusion on hemoglobin (Hb) variants in very low birth weight infants and to correlate these changes with parameters measured in routine complete blood counts.
Anemia is one of many problems encountered by very low birth weight infants. Anemia occurs because of frequent blood sampling, rapid growth with increased blood volume, shortened red blood cell (RBC) survival, and decreased RBC production. Although erythropoietin therapy has been useful in limiting anemia of prematurity when used, it has not replaced the need for blood transfusion in very low birth weight infants, especially during the time of most acute illness in the immediate neonatal period. 1 Eighty percent of infants with birth weights of Ͻ1500 gm require erythrocyte transfusion, with an average of 10 transfusions per infant. 2 Because standard criteria for erythrocyte transfusion in very low birth weight infants do not exist, various indications for transfusion are used in such infants, including replacement of blood drawn for laboratory studies, maintenance of hematocrit levels of Ͼ0.40 during severe respiratory disease, and maintenance of hematocrit levels of Ͼ0.30 in neonates with less severe cardiopulmonary problems or growth failure. 2 Relying solely on a certain hematocrit level for a given degree of illness does not take into consideration other factors involved in oxygen transport, including factors that may affect oxygen-hemoglobin (oxy-Hb) dissociation such as pH, temperature, 2,3-diphosphoglycerate, and Hb type.
After birth, there is a progressive slow change from synthesis of Hb F to Hb A in both term and preterm infants. 3, 4 As anemia develops in very low birth weight infants, neonatal RBCs with a predominance of Hb F are lost and with transfusion, adult donor RBCs with a predominance of Hb A are provided. With multiple transfusions, especially early in the hospital course of very low birth weight infants, there is a relatively rapid transition from Hb F to Hb A. Because Hb variants are not routinely quantified in neonatal care, this transition is typically not measured clinically.
Because neonatal RBCs have a higher mean corpuscular volume (MCV) than adult donor RBCs, the transition from neonatal RBCs with Hb F predominance to adult donor RBCs with Hb A predominance should be reflected by a decline in MCV. Unlike Hb variants, MCV is measured routinely in the complete blood count (CBC). Red cell distribution width (RDW), another parameter measured routinely in the CBC, reflects the heterogeneity of red cell size and is elevated in infants compared with adults. RDW is determined by dividing the SD of the MCV by the MCV and multiplying this result by 100. Thus, alterations in RDW may also reflect the transition from neonatal RBCs to adult donor RBCs.
The intent of this study was to use capillary isoelectric focusing to measure Hb variants in very low birth weight infants and correlate this with transfusion frequency and parameters such as MCV and RDW. This information would allow for an estimation of Hb variants present after transfusion in preterm infants based on information commonly available on routine CBC.
METHODS
Infants with birth weight of Ͻ1500 gm were eligible for enrollment at the time of hospital admission. All infants were hospitalized at a level Original Article
III referral neonatal intensive care unit with a neonatal transportderived population. No additional blood samples were obtained for the study. Blood samples were obtained by indwelling catheter when available or otherwise by capillary specimen. CBCs were obtained at the discretion of the attending physician. CBCs were performed with a Maxm Analyzer (Coulter Corporation, Miami, FL) on ϳ500 l of whole blood collected in ethylenediaminetetraacetic acid. Hb variants on randomly selected blood samples obtained for CBC were quantified by capillary isoelectric focusing using methods described previously. 5, 6 Briefly, 10 l of whole blood was used to prepare a hemolysate that was analyzed with a P/ACE 2200 system with ultraviolet detection and System Gold Software (Beckman Instruments, Fullerton, CA). A 50-m (internal diameter) ϫ 27-cm-coated capillary filled with 20 gm/liter of mixed ampholytes (2% pH 6 -8:3-10; 10:1) in 3.75 gm/liter methylcellulose was used for analysis. Cathode and anode solutions were 20 mM NaOH and 100 mM H 3 PO 4 in methylcellulose, respectively. Samples were applied using an autosampler with low-pressure injection, focused at 30 kV for 5 minutes, and then mobilized by simultaneous voltage and low pressure past the detector. Absorbance at 415 nm was measured by an automated data acquisition system. This process allows for the quantification of all routine Hb variants including Hbs A, A 1c , A 2 , F, S, and C. Because capillary isoelectric focusing allows for reliable quantification of Hb variants using a very small sample size (ϳ10 l whole blood), samples for analysis were obtained from blood remaining after CBC determination.
The attending neonatologist determined transfusion therapy. In general, transfusion of packed RBCs was performed to maintain hematocrit of Ͼ0.40 in infants requiring supplemental oxygen and mechanical ventilation, Ͼ0.30 in infants in infants requiring supplemental oxygen, and Ͼ0.25 in infants not on supplemental oxygen. Transfusions were 15 ml/kg of packed RBCs of hematocrit 65% stored in citrate phosphate dextrose adenine.
As no additional blood was obtained for the performance of this analysis, and patient confidentiality was maintained in the analysis, the study was exempt from the need for informed parental consent.
Data collected included gestational age and birth weight on each infant, MCV, RDW, Hb variant analysis, and transfusion record. Gestational age, birth weight, and the percentage of different Hb variants are expressed as means Ϯ SD. Correlation between MCV and Hb F content and RDW and Hb F was performed using Pearson's r test.
RESULTS
A total of 25 very low birth weight infants with a mean birth weight of 888 Ϯ 196 gm and a gestational age of 26.7 Ϯ 1.8 weeks were enrolled, with 126 total specimens analyzed for this study. All infants enrolled required at least one transfusion (range 1 to 19 transfusions), with a mean of seven transfusions per infant during their hospital course. The number of transfusions received was inversely correlated with birth weight and gestational age.
Data comparing the percentage of Hb F with the number of transfusions given during the first month of life are presented in Figure 1 .
The mean Hb F content before transfusion was 87.1%, and it decreased to 54.0% after one transfusion. With multiple transfusions, there was a progressive decline in mean Hb F content such that Hb F made up Ͻ15% of the total Hb after five transfusions had been given in the first month of life.
A scatter plot comparing Hb F content with MCV from all 126 samples is presented in Figure 2 . This data were accumulated throughout the hospital stay of enrolled patients, including specimens beyond the first month of life. There was a linear correlation between these two variables, with a correlation coefficient of 0.77 and a p value of Ͻ0.0001. The percentage of Hb F could be predicted from the MCV by the following formula: Hb F (%) ϭ (2.6 ϫ MCV) Ϫ 215. When the MCV fell below 100 fl, the Hb F content was Ͻ50% in 84 of 97 samples (positive predictive value 87%, negative predictive value 90%). When the MCV fell below 95 fl, the Hb F content was Ͻ25% in 58 of 79 samples (positive predictive value 73%, negative predictive value 94%). There were no differences noted in this relationship between samples obtained by indwelling catheter compared with capillary specimens.
There was less of a correlation between Hb F content and RDW (r ϭ 0.33, p ϭ 0.0003). With additional linear regression analysis, the relationship between Hb F and RDW was shown to be nonlinear by runs test ( p Ͻ 0.0001). When similar amounts of Hb F and Hb A were present, the RDW was typically higher than when there was a predominance of either Hb F or Hb A present. RDW values of Ͼ17% typically occurred when a mixture of Hb F and Hb A was present, whereas RDW values of Ͻ17% typically represented a predominance of either Hb.
Figures 3 and 4 display data from two illustrative patients. Figure  3 reveals data from the hospital course of an infant born at 27 weeks' gestation weighing 726 gm. This infant had the longest hospital course of all infants studied. Before transfusion, his Hb variants included 96.4% Hb F, 2.1% Hb A, and 1.5% Hb S, a pattern consistent with sickle cell trait. MCV at this time was 123.4 fl. With multiple transfusions beginning on day 2 of life, there was a progressive decline in MCV and Hb F and an increase in Hb A. After three transfusions, Hb S was no longer detectable. After receiving his fifteenth packed RBC transfusion on day 73 of life, the infant was able to maintain an adequate hematocrit on his own for the duration of the hospital course. During this transfusion-free period, a rise in Hb F, a decline in Hb A, and a reappearance of Hb S was observed on subsequent analyses. Figure 4 displays data from the first 10 days of the hospital course for an infant born at 28 weeks' gestation weighing 1070 gm. This infant required transfusion shortly after birth at a referring hospital; thus no pretransfusion Hb variant analysis is available. In the first 2 days of life, this infant underwent three packed RBC transfusions, with a resulting decline in Hb F and MCV and a corresponding increase in Hb A. On day 3 of life, this infant underwent a double volume exchange transfusion due to hyperbilirubinemia. After the exchange transfusion, Hb A accounted for Ͼ90% of the circulating Hb, whereas Hb F accounted for Ͻ10%.
DISCUSSION
This study examines the effects of transfusion therapy on Hb variants in very low birth weight infants. As has been reported previously, the infants in this study required frequent packed RBC transfusions to correct anemia associated with multiple problems of prematurity. 2 Although not all infants with a birth weight of Ͻ1500 gm will require transfusion, the finding that all infants in this study required transfusion results from the fact that the very low birth weight infants referred to this neonatal intensive care unit have significant illness necessitating their transfer. The need for transfusion was greatest in the smallest and most premature infants, likewise reflecting increased illness severity and resulting need for transfusion.
Hb F, the predominant Hb of the fetus and neonate, is progressively replaced postnatally by Hb A in a process that is dependent on postconceptional age. 4 Certain disease states, including chronic lung disease, cyanotic heart disease, and anemia, may delay the switchover to Hb A production. [7] [8] [9] This study demonstrates a rapid transition from Hb F to Hb A predominance in very low birth weight infants who are given multiple transfusions within a limited period. After two 15 ml/kg packed RBC transfusions within the first month of life, Hb A surpasses Hb F as the predominant Hb of these very low birth weight infants.
The transition from Hb F to Hb A is reflected by a decline in the MCV. The positive correlation between Hb F and MCV is such that the MCV may be used to reliably predict the Hb F content in most of these infants. The formula Hb F (%) ϭ (2.6 ϫ MCV) Ϫ 215 can be used to predict the percentage of Hb F in very low birth weight infants during the acute stages of their hospital course. Viewed another way, the percentage of Hb F typically falls below 50% when the MCV falls below 100 fl, and the percentage of Hb F falls below 25% when the MCV falls below 95 fl. This ability to predict Hb F content in transfused preterm infants allows the clinician to consider Hb F content in deciding whether or not to transfuse an infant in situations in which the need for transfusion is debatable. The nonlinear relationship between Hb F and RDW was such that a higher RDW suggested a mixture of Hb F and Hb A, whereas a lower RDW suggested a predominance of one Hb. This observation is consistent with the manner in which the RDW is determined based on the SD of the MCV. When significant amounts of both Hbs are present, a more heterogeneous mixture of both neonatal and transfused adult cells is present, thus increasing the SD of the MCV, and subsequently increasing the RDW.
The replacement of Hb F with Hb A has clinical implications because of its effects on the oxy-Hb dissociation curve. The rightward shift of the oxy-Hb curve as Hb A replaces Hb F results in less oxygen affinity in pulmonary capillaries but greater release of oxygen in metabolically active tissues. Compared with those infants with Hb F predominance, multiply transfused preterm infants with Hb A predominance are better able to unload oxygen at the tissue level, but may be less able to bind oxygen in the lung under conditions of low PaO 2. Conversely, preterm infants with Hb F predominance are better suited to bind oxygen in the lung at low PaO 2 concentrations, but less able to unload oxygen in tissues.
There are important differences in blood oxygen content based solely on the type of Hb present. The oxygen content equation and standard oxy-Hb dissociation curves can be used to illustrate the effect of Hb type on oxygen content. If one assumes a Hb content of 15 gm/dl and a pO 2 of 50 torr, the oxygen content for a preterm newborn before transfusion (with Hb F accounting for 90% of the Hb present) would be 19.0 ml of O 2 per 100 ml of blood (based on 94% O 2 saturation for Hb F at this pO 2 ). In this same infant 1 week later (after three transfusions have reduced the amount of Hb F to 30% of the total Hb present), at the same Hb concentration of 15 gm/dl and a pO 2 of 50 torr, the oxygen content would be reduced to 17.2 ml of O 2 per 100 ml of blood (based on 85% O 2 saturation for this Hb mixture at this pO 2 ). Although such differences in oxygen content are important, also important is the ability of Hb to release oxygen at the tissue level. For any individual patient, multiple other factors including pH, PCO 2 , temperature, and 2,3-diphosphoglycerate may also play a role in the oxy-Hb dissociation curve.
After cessation of frequent transfusions in these infants, there was a gradual increase in the percentage of Hb F and a decrease in the percentage of Hb A, indicative of ongoing Hb F production at that postconceptional age. These changes and their timing are consistent with previous observations. 10, 11 As the percentage of Hb F increased after transfusion therapy was completed, there was no subsequent increase observed in MCV. This is not unexpected given the gradual fall in MCV that is known to occur postnatally in these infants. 12 Thus, the rise in the percentage of Hb F and the fall in the percentage of Hb A in the period after transfusion therapy is completed can be expected based on these and other observations, but not predicted by MCV.
Capillary isoelectric focusing has been shown to be an easy and reliable method to assess Hb variants. 5, 6, 13 The ability to assess Hb variants using such a small sample size makes this method ideal for use in both premature and term infants. As shown in Figure 3 , capillary isoelectric focusing can identify very small amounts of abnormal Hb variants. In this patient, the initial presence of a small amount of Hb S is followed by its subsequent disappearance with transfusion. After transfusion, the reappearance of a small percentage of Hb S is shown.
In conclusion, this study shows that very low birth weight infants receive multiple RBC transfusions, resulting in a rapid transition from Hb F to Hb A. In the smallest and most premature infants with the greatest need for transfusions, this transition is most rapid. When available, capillary isoelectric focusing to determine Hb variants offers a reliable method to monitor this transition. When Hb variant analysis is not used, the transition from Hb F to Hb A can be predicted based on the MCV, which is readily available from CBC analysis.
